Patent application number | Description | Published |
20100227809 | COMBINATION TREATMENT FOR METABOLIC DISORDERS - Various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis can be treated with a compound selected from an incretin mimetic and a dipeptidyl peptidase IV inhibitor in combination with a Compound of Formula, I or a pharmaceutically acceptable salt thereof, Formula (I) Three of R | 09-09-2010 |
20110014176 | COMPOUNDS AND METHOD FOR REDUCING URIC ACID - This invention pertains to the discovery that certain extracts of licorice, particularly when formulated as a candy or lollipop or other means that provides an extended release (e.g., greater than about 4 minutes) to the oral cavity significantly inhibits the formation of dental caries in a human subject. | 01-20-2011 |
20110206653 | TETRAZOLE COMPOUNDS FOR REDUCING URIC ACID - Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula I. The uric acid-lowering effects of the compounds of this invention are used to treat or prevent a variety of conditions including gout, hyperuricemia, elevated levels of uric acid that do not meet the levels customarily justifying a diagnosis of hyperuricemia, renal dysfunction, kidney stones, cardiovascular disease, risk for developing cardiovascular disease, tumor-lysis syndrome, cognitive impairment, early-onset essential hypertension, and | 08-25-2011 |
20130137629 | COMBINATION TREATMENT FOR METABOLIC DISORDERS - Various metabolic disorders, such as insulin resistance syndrome, diabetes, polycystic ovary syndrome, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis can be treated with a compound selected from an incretin mimetic and a dipeptidyl peptidase IV inhibitor in combination with a Compound of Formula I or a pharmaceutically acceptable salt thereof | 05-30-2013 |
20130259850 | COMPOUNDS AND METHOD FOR REDUCING URIC ACID - Uric acid in mammalian subjects is reduced and excretion of uric acid is increased by administering a compound of Formula I or a pharmaceutically acceptable salt thereof. | 10-03-2013 |
Patent application number | Description | Published |
20110209742 | Method and Structure for a Cool Roof by Using a Plenum Structure - A plenum structure for cooling both a roof and a solar module includes an upper surface comprising at least a portion of a bottom face of a solar module having a length and a width and an under surface comprising a top face of a pan structure disposed a first vertical spacing directly below the upper surface and a second vertical spacing above the roof. The plenum structure includes a first side face and a second side face respectively coupled to the upper surface and the under surface, a first end face and a second end face respectively coupled to upper surface, the under surface, the first side face, and the second side face to enclose a spatial volume defined by the length, the width, and the first vertical spacing. | 09-01-2011 |
20110223850 | METHOD AND SYSTEM OF VENTILATION FOR A HEALTHY HOME CONFIGURED FOR EFFICIENT ENERGY USAGE AND CONSERVATION OF ENERGY RESOURCES - A method provides a ventilation control compliant with an adopted ventilation standard for efficient energy usage and conservation of energy resources. The method includes operating a home energy system to generate solar energy within a daily active period and draw fresh air from an ambient region, setting a daily ventilation period as a fractional period of a day, the ventilation period being coincident with the active period during a heating period for the home or a time period after the active period during a cooling period for the home, determining a target volume, determining a flow rate for delivering the fresh air during the ventilation period, performing ventilation in the ventilation period to deliver the fresh air into the home using the flow rate, and monitoring an accumulated total ventilation volume of the delivered fresh air until the accumulated total ventilation volume is within a vicinity of a target volume. | 09-15-2011 |
20110238223 | METHOD AND SYSTEM FOR HEALTHY HOME ZONING CONTROL CONFIGURED FOR EFFICIENT ENERGY USE AND CONSERVATION OF ENERGY RESOURCES - A system provides space conditioning zone control in a building for efficient energy use and conservation of energy resources. The system includes an energy transfer module coupled to a solar thermal system to receive a first airflow and an auxiliary thermal module coupled to the energy transfer module for processing a return airflow to provide a conditioned airflow for one or more spatial zones. The system further includes a zone controller coupled directly to the auxiliary thermal module and a thermostat in each spatial zone for operating the auxiliary thermal module. Furthermore, the system includes a master control module wirelessly communicated with each thermostat and configured to operate the energy transfer module. The master control module initiates a transfer of the first airflow based upon a first setpoint before the zone controller initiates a generation and transfer of the conditioned airflow based upon a second setpoint. | 09-29-2011 |
20110257795 | THERMOSTAT METHOD AND SYSTEM FOR CONTROLLING SOLAR ENERGY UTILIZATION FOR EFFICIENT ENERGY USAGE AND CONSERVATION OF ENERGY RESOURCES - A system for controlling solar energy utilization for efficient energy usage and conservation of energy resources for providing space conditioning and home ventilation. The system includes a control module configured to operate a solar energy system for collecting a flow of fresh air for utilizing thermal energy converted by the solar energy system. Additionally, the system includes a thermostat module directly coupled with an HVAC system to for controlling a delivery of a conditioned airflow. The thermostat device couples wirelessly to the control module. Further, the system includes a graphic user interface operably communicating with the control module remotely via a network hub. The graphic user interface device is configured to set modes of operation for the thermostat module and configured to communicate with the thermostat module for transmitting control information, modes of operation, and temperature information of the building structure to the control module via a wireless transmission. | 10-20-2011 |
20120024343 | Method and Structure for a Cool Roof by Using a Plenum Structure - A method for providing a cool roof by processing fluid within a vicinity of a roof structure having a surface area includes transferring a volume of air with a selected flow rate through a plenum structure disposed underlying one or more solar modules and coupled to the roof structure spatially over a height above a portion of the surface area. Each of the one or more solar modules is coupled to each other. The plenum structure has at least an intake region and an exit region for the volume of air. The method additionally includes maintaining a roof temperature profile for the portion of the surface area starting from the intake region to the exit region for a predetermined amount of time using at least the flow rate of the volume of air being transported through the plenum structure. The roof temperature profile comprises a first temperature value substantially equal to an ambient air temperature at the intake region to a second temperature value in the vicinity of the exit region depending on the flow rate and substantially smaller than a temperature of bare roof structure outside the portion of the surface area. | 02-02-2012 |
Patent application number | Description | Published |
20090042968 | THERAPEUTIC COMPOSITIONS FOR INTRANASAL ADMINISTRATION OF KETOROLAC - Therapeutic compositions, particularly sprayable aqueous compositions, comprise ketorolac or a pharmaceutically acceptable salt, in combination with a local anesthetic, such as lidocaine hydrochloride. The compositions are nasally administered to a subject in need thereof to treat pain or inflammation and have the benefit of reduced stinging and improved efficacy, compared to known nasally administered compositions. | 02-12-2009 |
20100016402 | UNIT DOSE FORMULATIONS OF KETOROLAC FOR INTRANASAL ADMINISTRATION - This invention relates to therapeutic compositions, particularly sprayable aqueous compositions, and unit dose formulations comprise ketorolac or a pharmaceutically acceptable salt, alone or in combination with lidocaine or a pharmaceutically acceptable salt thereof. The compositions are nasally administered to a subject in need thereof to treat pain or inflammation. | 01-21-2010 |
20100233024 | DEVICE FOR INTRANASAL ADMINISTRATION - Disclosed herein are vials and devices containing a ketorolac solution for intranasal administration and a head space comprising no more than about 10% v/v oxygen and which vials and devices are stored in an oxygen-impermeable pouch. Also disclosed are processes for preparing the vials and devices. | 09-16-2010 |
20100233099 | DEVICE FOR INTRANASAL ADMINISTRATION - Disclosed herein are devices and processes for preparing a vial for an intranasal administration of a medicament where the vial comprises reduced oxygen content. | 09-16-2010 |
20120329849 | UNIT DOSE FORMULATIONS OF KETOROLAC FOR INTRANASAL ADMINISTRATION - This invention relates to therapeutic compositions, particularly sprayable aqueous compositions, and unit dose formulations comprise ketorolac or a pharmaceutically acceptable salt, alone or in combination with lidocaine or a pharmaceutically acceptable salt thereof. The compositions are nasally administered to a subject in need thereof to treat pain or inflammation. | 12-27-2012 |
20130000634 | DEVICE FOR INTRANASAL ADMINISTRATION - Disclosed herein are devices and processes for preparing a vial for an intranasal administration of a medicament where the vial comprises reduced oxygen content. | 01-03-2013 |
20130186391 | DEVICE FOR INTRANASAL ADMINISTRATION OF KETOROLAC - Disclosed herein are vials and devices containing a ketorolac solution for intranasal administration and a head space comprising no more than about 10% v/v oxygen and which vials and devices are stored in an oxygen-impermeable pouch. Also disclosed are processes for preparing the vials and devices. | 07-25-2013 |
20140112986 | PROLIPOSOMAL TESTOSTERONE FORMULATIONS - Novel testosterone formulations are disclosed where testosterone is incorporated into a phospholipid/cholesterol system to produce a proliposomal powder dispersion. The proliposomal powder dispersions of the invention may be formulated with pharmaceutically acceptable excipients to form pharmaceutical compositions. Enterically coated oral dosage forms are disclosed as are methods of treatment for testosterone replacement therapy. | 04-24-2014 |